TMTC2 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 3.484400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
3.515400E-01
Normal-vs-Stage2
2.775400E-01
Normal-vs-Stage3
7.663800E-01
Normal-vs-Stage4
2.438000E-01
Stage1-vs-Stage2
6.683800E-01
Stage1-vs-Stage3
2.045400E-01
Stage1-vs-Stage4
8.465400E-01
Stage2-vs-Stage3
1.082170E-01
Stage2-vs-Stage4
5.078200E-01
Stage3-vs-Stage4
1.334030E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
3.630600E-01
Normal-vs-AfricanAmerican
2.787000E-01
Normal-vs-Asian
5.263200E-01
Caucasian-vs-AfricanAmerican
4.594200E-01
Caucasian-vs-Asian
8.853200E-01
AfricanAmerican-vs-Asian
5.589600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
2.955800E-01
Normal-vs-Female
4.381400E-01
Male-vs-Female
3.385200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
9.176200E-01
Normal-vs-Age(41-60Yrs)
1.775380E-01
Normal-vs-Age(61-80Yrs)
4.462800E-01
Normal-vs-Age(81-100Yrs)
6.515600E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
1.488620E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
3.763400E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
5.795800E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
4.421000E-03
Age(41-60Yrs)-vs-Age(81-100Yrs)
8.587500E-02
Age(61-80Yrs)-vs-Age(81-100Yrs)
6.950600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
3.943600E-01
Normal-vs-Daily Drinker
5.635800E-01
Normal-vs-Weekly Drinker
4.953800E-01
Normal-vs-Occasional Drinker
2.911400E-01
Normal-vs-Social Drinker
2.924400E-01
Non Drinker-vs-Daily Drinker
5.581400E-01
Non Drinker-vs-Weekly Drinker
8.146200E-01
Non Drinker-vs-Occasional Drinker
4.141000E-01
Non Drinker-vs-Social Drinker
8.752000E-01
Daily Drinker-vs-Weekly Drinker
7.973200E-01
Daily Drinker-vs-Occasional Drinker
2.180800E-01
Daily Drinker-vs-Social Drinker
6.847200E-01
Weekly Drinker-vs-Occasional Drinker
3.971400E-01
Weekly Drinker-vs-Social Drinker
9.215400E-01
Occasional Drinker-vs-Social Drinker
3.553800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
2.299400E-01
Normal-vs-Grade 2
6.770200E-02
Normal-vs-Grade 3
3.003900E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
1.562690E-03
Grade 1-vs-Grade 3
2.039200E-03
Grade 1-vs-Grade 4
2.299400E-01
Grade 2-vs-Grade 3
6.879800E-01
Grade 2-vs-Grade 4
6.770200E-02
Grade 3-vs-Grade 4
3.003900E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
4.159600E-01
Normal-vs-NonDiabetic
4.085800E-01
Diabetic-vs-NonDiabetic
9.186400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
8.300400E-02
Normal-vs-NoPancreatitis
4.365000E-01
Pancreatitis-vs-NoPancreatitis
5.060200E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
4.604800E-01
Normal-vs-N1
2.915800E-01
N0-vs-N1
1.699960E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
1.576370E-01
Normal-vs-TP53-NonMutant
4.138200E-01
TP53-Mutant-vs-TP53-NonMutant
5.736200E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
